Analyst Reco. BioNTech SE Börse Stuttgart

Equities

Real-time Estimate Tradegate Other stock markets 04:56:34 20/05/2024 pm IST			5-day change	1st Jan Change
83.42 ^EUR	+0.21%		-3.65%	-5.76%

17/05	Sector Update: Health Care Stocks Mixed Late Afternoon	MT
17/05	Sector Update: Health Care Stocks Softer Friday Afternoon	MT

Arbutus Biopharma Urged to Stop Share Issuances, Explore Alternatives for Hepatitis B Program	17/05	MT
Evercore ISI Starts BioNTech With In Line Rating, $100 Price Target	14/05	MT
BIONTECH : UBS remains Neutral	10/05	ZD
HC Wainwright Raises BioNTech SE Price Target to $113 From $107, Maintains Buy Rating	08/05	MT
BIONTECH : Deutsche Bank reaffirms its Neutral rating	08/05	ZD
TD Cowen Adjusts BioNTech Price Target to $98 From $95, Maintains Hold Rating	07/05	MT
BMO Capital Adjusts BioNTech Price Target to $122 From $123, Maintains Outperform Rating	07/05	MT
BIONTECH : Goldman Sachs reiterates its Neutral rating	07/05	ZD
BIONTECH : Jefferies gives a Neutral rating	06/05	ZD
BIONTECH : Gets a Neutral rating from Deutsche Bank	23/04	ZD
UBS Cuts BioNTech Price Target to $101 From $110, Maintains Neutral Rating	27/03	MT
BIONTECH : Deutsche Bank remains Neutral	22/03	ZD
TD Cowen Adjusts BioNTech Price Target to $95 From $101, Maintains Market Perform Rating	21/03	MT
BIONTECH : A miss is a miss	21/03
BIONTECH : Deutsche Bank reaffirms its Neutral rating	21/03	ZD
BIONTECH : Goldman Sachs reiterates its Neutral rating	21/03	ZD
BIONTECH : Jefferies sticks Neutral	21/03	ZD
BIONTECH : UBS gives a Neutral rating	20/03	ZD
BMO Capital Initiates Coverage on BioNTech With Outperform Rating, $127 Price Target	23/02	MT
Canaccord Genuity Adjusts Price Target on BioNTech to $171 From $168, Maintains Buy Rating	20/02	MT

No results for this search

BIONTECH : A miss is a miss

March 21, 2024 at 06:57 pm IST